Baylor Genetics
Private Company
Total funding raised: $152.5M
Overview
Baylor Genetics is a Houston-based, privately held diagnostic company founded in 2011, with a legacy tracing back nearly 50 years through its affiliation with Baylor College of Medicine. It has established itself as a leader in clinical genetic testing, having performed over 4 million tests worldwide, and is at the forefront of integrating whole genome sequencing (WGS), artificial intelligence, and multimodal data analysis. The company's business model is service-based, providing end-to-end diagnostic solutions supported by a world-class team of clinical experts, and it is actively expanding its technological capabilities and EHR integrations to solidify its market position in precision diagnostics.
Technology Platform
Clinical-grade genomic sequencing (WGS, WES, panels) enhanced with Optical Genome Mapping, Long-Read Sequencing, and a proprietary AI-driven analysis pipeline for variant prioritization and interpretation. Integrated with Epic Aura EHR for result delivery.
Funding History
4Opportunities
Risk Factors
Competitive Landscape
Baylor Genetics competes with large commercial reference labs (e.g., Quest Diagnostics, Labcorp), specialized genomic firms (e.g., Invitae, Ambry Genetics), and academic medical center labs. Its differentiation lies in its deep clinical expertise, affiliation with Baylor College of Medicine, comprehensive service model, and pioneering work in whole genome sequencing and EHR integration.